Your browser doesn't support javascript.
loading
Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
Ning, Tingting; Nie, Jianhui; Huang, Weijin; Li, Changgui; Li, Xuguang; Liu, Qiang; Zhao, Hui; Wang, Youchun.
Afiliação
  • Ning T; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, Beijing, China.
  • Nie J; Graduate School of Peking Union Medical College, Beijing, China.
  • Huang W; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, Beijing, China.
  • Li C; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, Beijing, China.
  • Li X; Division of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
  • Liu Q; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada.
  • Zhao H; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, Beijing, China.
  • Wang Y; Division of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
J Infect Dis ; 219(1): 19-25, 2019 01 01.
Article em En | MEDLINE | ID: mdl-29982588
ABSTRACT

Background:

Since the emergence of influenza A(H7N9) virus in 2013, there have been 5 waves of influenza A(H7N9) epidemics in China. However, evolution of the hemagglutinin (HA) protein antigenicity has not been systematically investigated.

Methods:

To better understand how antigenic drift in HA proteins of influenza (A)H7N9 virus occurs, 902 influenza A(H7N9) virus HA protein sequences from a public database were retrieved and analyzed. Fifty-three mutants with single amino acid substitutions in HA protein were introduced into pseudoviruses, and their antigenic characteristics were analyzed using pseudovirus-based assays.

Results:

The frequencies of 9 mutations incrementally increased over the past 5 years, with mutations identified at multiple sites. While mean neutralization titers of most variants remained unchanged, 3 mutations, A143V, A143T, and R148K, displayed a median 4-fold lower susceptibility to neutralization by antisera against influenza A/Anhui/1/2013(H7N9) virus. Notably, A143V and A143T were located outside the previously reported antigenic sites. The most dominant variant (A143V/R148K) in the most recent season constituted 74.11% of all mutations and demonstrated a 10-fold reduction in its reactivity to influenza A/Anhui/1/2013(H7N9) virus antisera. Importantly, compared with the DNA construct without the corresponding HA protein mutation, DNA vaccine encoding the A143V/R148K mutant induced a 5-fold increase in the neutralizing activity against this circulating virus.

Conclusions:

An appropriate vaccine strain should be considered in response to increasing antigenic drift in influenza A(H7N9) virus HA protein.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Hemaglutininação de Vírus da Influenza / Substituição de Aminoácidos / Subtipo H7N9 do Vírus da Influenza A / Antígenos Virais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Hemaglutininação de Vírus da Influenza / Substituição de Aminoácidos / Subtipo H7N9 do Vírus da Influenza A / Antígenos Virais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article